{"id":"NCT01773928","sponsor":"Alachua Government Services, Inc.","briefTitle":"Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)","officialTitle":"Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-01","primaryCompletion":"2013-04","completion":"2013-04","firstPosted":"2013-01-23","resultsPosted":"2025-09-11","lastUpdate":"2025-09-11"},"enrollment":1928,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"Vero cell-derived trivalent influenza vaccine manufactured with the modified manufacturing process (VCIV modified)","otherNames":[]},{"type":"BIOLOGICAL","name":"VCIV manufactured with the current manufacturing process (VCIV current)","otherNames":[]},{"type":"BIOLOGICAL","name":"Fluzone®, licensed trivalent influenza vaccine (TIV)","otherNames":[]}],"arms":[{"label":"VCIV - Modified manufacturing process (18-49 Years Old) Lot 1","type":"EXPERIMENTAL"},{"label":"VCIV - Modified manufacturing process (18-49 Years Old) Lot 2","type":"EXPERIMENTAL"},{"label":"VCIV - Modified manufacturing process (18-49 Years Old) Lot 3","type":"EXPERIMENTAL"},{"label":"VCIV manufactured with current process (18-49 Years Old)","type":"ACTIVE_COMPARATOR"},{"label":"Fluzone® (18-49 Years Old)","type":"ACTIVE_COMPARATOR"},{"label":"VCIV - Modified manufacturing process (≥50 Years Old) Lot 1","type":"EXPERIMENTAL"},{"label":"VCIV - Modified manufacturing process (≥50 Years Old) Lot 2","type":"EXPERIMENTAL"},{"label":"VCIV - Modified manufacturing process (≥50 Years Old) Lot 3","type":"EXPERIMENTAL"},{"label":"Fluzone® (≥50 Years Old)","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to determine if a Vero cell-derived trivalent seasonal influenza vaccine produced by the modified manufacturing process:\n\n1. induces immune responses comparable to that produced by the current manufacturing process\n2. has an acceptable safety profile compared to a licensed trivalent seasonal influenza vaccine\n3. demonstrates consistency of immune response among three different lots.","primaryOutcome":{"measure":"Hemagglutination Inhibition Antibody (HIA) Titer for Each of the Three Antigens Contained in the Vaccine","timeFrame":"21 days post vaccination","effectByArm":[{"arm":"VCIV - Modified Manufacturing Process (18-49 Years Old) Lot 1","deltaMin":269.7,"sd":null},{"arm":"VCIV - Modified Manufacturing Process (18-49 Years Old) Lot 2","deltaMin":337.3,"sd":null},{"arm":"VCIV - Modified Manufacturing Process (18-49 Years Old) Lot 3","deltaMin":288.5,"sd":null},{"arm":"Total VCIV - Modified Process (18 - 49 Years Old) Lots 1-3","deltaMin":297.1,"sd":null},{"arm":"VCIV Manufactured With Current Process (18-49 Years Old)","deltaMin":264.4,"sd":null},{"arm":"Fluzone® (18-49 Years Old)","deltaMin":595.6,"sd":null},{"arm":"VCIV - Modified Manufacturing Process (≥50 Years Old) Lot 1","deltaMin":141.3,"sd":null},{"arm":"VCIV - Modified Manufacturing Process (≥50 Years Old) Lot 2","deltaMin":118.3,"sd":null},{"arm":"VCIV - Modified Manufacturing Process (≥50 Years Old) Lot 3","deltaMin":112.8,"sd":null},{"arm":"Total VCIV - Modified Process (≥50 Years Old) Lots 1-3","deltaMin":123.7,"sd":null},{"arm":"Fluzone® (≥50 Years Old)","deltaMin":306.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":7,"exclusionCount":17},"locations":{"siteCount":20,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":200},"commonTop":["Injection site pain","Malaise","Headache","Fatigue","Myalgia"]}}